Lundbeck Lifted By Leap In Migraine Therapy Sales

Charl van Zyl
Charl van Zyl, CEO, Lundbeck (Søren Svendsen/Lundbeck)
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Earnings

More from Therapy Areas